Pharmacokinetic Differences between Pantoprazole Enantiomers in Rats
- 435 Downloads
The purpose of this study was to quantitatively clarify the contribution of the absorption, protein binding, and metabolism of cytochrome P450 enzymes to the enantioselective pharmacokinetics of pantoprazole enantiomers in rats.
The enantioselective pharmacokinetics of pantoprazole enantiomers was estimated by an oral administration of racemic pantoprazole to rats. The pharmacokinetic differences between pantoprazole enantiomers were evaluated by the experiments of the in situ perfusion into rat small intestine, the protein binding, and the in vitro metabolism in rat liver microsomes of pantoprazole enantiomers.
The mean area under the curve value of S-pantoprazole was 1.5 times greater than that of R-pantoprazole after administration of racemic pantoprazole to rats (20 mg/kg, p.o.). There were significant differences in ke (p < 0.05), t1/2 (p < 0.01), and mean residence time (p < 0.01) values between the two enantiomers. In the in situ absorption study, the absorption rate constants were of no significant differences between the two enantiomers. The mean unbound fraction of R-pantoprazole was slightly greater than that of S-pantoprazole. The intrinsic clearance (CLint) of the formation of the 5′-O-demethyl metabolite from S-pantoprazole was 4-fold lower than that from R-pantoprazole. However, the CLint value for the sulfone and 6-hydroxy metabolites from S-pantoprazole was higher than that from R-pantoprazole. The sum of the CLint of the formation of all three metabolites was 3.06 and 4.82 mL/min/mg protein for S- and R-pantoprazole, respectively.
This study suggests that the enantioselective pharmacokinetics of pantoprazole enantiomers in rats is probably ascribable to their enantioselective metabolism, which is contributed by all the three metabolic pathways, including sulfoxide oxidation, 4′-O-demethylation, and 6-hydroxylation.
Key wordsenantiomer enantioselectivity metabolism pantoprazole pharmacokinetics
This work was supported in part by Grant 2003AA2Z347C of the “863” Program of China.
- 4.Simon, W. A. 1995Pantoprazole—Which cytochrome P450 isoenzymes are involved in its biotransformationGut37A135Google Scholar
- 5.Cairns, A. M., Chiou, R. H., Rogers, J. D., Demetriades, J. L. 1995Enantioselective high-performance liquid chromatographic determination of omeprazole in human plasmaJ. Chromatogr.666323328Google Scholar
- 9.Katsuki, H., Yagi, H., Arimori, K., Nakamura, C., Nakano, M., Katafuchi, S., Fujioka, Y., Fujiyama, S. 1996Determination of R(+)- and S(−)-lansoprazole using chiral stationary-phase liquid chromatography and their enantioselective pharmacokinetics in humansPharm. Res.13611615CrossRefPubMedGoogle Scholar
- 11.Takakuwa, S., Chiku, S., Nakata, H., Yuzuriha, T., Mano, N., Asakawa, N. 1995Enantioselective high-performance liquid chromatographic assay for determination of the enantiomers of a new anti-ulcer agent, E3810, in Beagle dog plasma and rat plasmaJ. Chromatogr., B673113122Google Scholar
- 12.Mano, N., Oda, Y., Takakuwa, S., Chiku, S., Nakata, H., Asakawa, N. 1996Plasma direct injection high-performance liquid chromatographic method for simultaneous determining E3810 enantiomers and their metabolites by using flavoprotein-conjugated columnJ. Pharm. Sci.85903907CrossRefPubMedGoogle Scholar
- 24.Xie, Z. Y., Yang, B. H., Zhang, Y. F., Zhong, D. F. 2004Studies on chiral inversion of dextro-pantoprazole in humanActa Pharm. Sin.39370373Google Scholar
- 25.Mano, N., Oda, Y., Takakuwa, S., Yuzuriha, T., Mano, N., Asakawa, N. 1996Plasma direct injection high-performance liquid chromatographic method for simultaneously determining E3810 enantiomers and their metabolites by using flavoprotein-conjugated columnJ. Pharm. Sci.85903907CrossRefPubMedGoogle Scholar
- 26.Stenhoff, H., Blomqvist, A., Lagerstrom, P. O. 1999Determination of the enantiomers of omeprazole in blood plasma by normal-phase liquid chromatography and detection by atmospheric pressure ionization tandem mass spectrometryJ. Chromatogr., B734191201Google Scholar